ArticleResults in immunology2012

A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.

Pedro C Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.